MET and non-small cell lung carcinoma: For patients with NSCLC, the following molecular alterations were reported: RET alterations in 24 patients, MET alterations in 12 patients, CBL alterations in ten patients, Chr4q12 amplification in four patients and AXL, KDR and NTRK alterations in one patient each.